Michael Jordan Friedman - 15 Jan 2024 Form 4 Insider Report for INNOVATIVE MEDTECH, INC. (IMTH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jan 2024, 17:00:46 UTC
Prior SEC filing
19 Jan 2022
Next SEC filing
07 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Jordan Friedman

Key filing fact

Michael Jordan Friedman filed Form 4 for INNOVATIVE MEDTECH, INC. (IMTH) on 17 Jan 2024.

Key facts

  • This page summarizes Michael Jordan Friedman's Form 4 filing for INNOVATIVE MEDTECH, INC. (IMTH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jan 2024, 17:00.

Change

  • Previous filing in this sequence was filed on 19 Jan 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMTH transaction Derivative

Option

Award

Transaction value
$0
Shares
+3,750,000
Change %
+268%
Price
$0.000000
Shares after
5,150,000
Date
15 Jan 2024
Ownership
By Red Halo, LLC
Underlying class
Common Stock
Underlying amount
3,750,000
Exercise price
$0.5000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options issued for employment services rendered.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .